Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terns Pharmaceuticals (TERN) Total Current Liabilities: 2020-2022

Historic Total Current Liabilities for Terns Pharmaceuticals (TERN) over the last 3 years, with Dec 2022 value amounting to $8.5 million.

  • Terns Pharmaceuticals' Total Current Liabilities rose 61.57% to $12.1 million in Q3 2023 from the same period last year, while for Sep 2023 it was $12.1 million, marking a year-over-year increase of 61.57%. This contributed to the annual value of $8.5 million for FY2022, which is 24.16% up from last year.
  • Per Terns Pharmaceuticals' latest filing, its Total Current Liabilities stood at $8.5 million for FY2022, which was up 24.16% from $6.8 million recorded in FY2021.
  • In the past 5 years, Terns Pharmaceuticals' Total Current Liabilities ranged from a high of $22.8 million in FY2020 and a low of $6.8 million during FY2021.
  • Moreover, its 3-year median value for Total Current Liabilities was $8.5 million (2022), whereas its average is $12.7 million.
  • As far as peak fluctuations go, Terns Pharmaceuticals' Total Current Liabilities plummeted by 70.12% in 2021, and later grew by 24.16% in 2022.
  • Yearly analysis of 3 years shows Terns Pharmaceuticals' Total Current Liabilities stood at $22.8 million in 2020, then tumbled by 70.12% to $6.8 million in 2021, then increased by 24.16% to $8.5 million in 2022.